Crossmark

Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor

Crossref DOI link: https://doi.org/10.1007/s12033-023-00680-8

Published Online: 2023-02-03

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chatterjee, Prarthana

Karn, Rohit

Emerson, I. Arnold

Banerjee, Satarupa https://orcid.org/0000-0002-0986-2796
License Information

Text and Data Mining valid from 2023-02-03

Version of Record valid from 2023-02-03
More Information

Article History

Received: 31 August 2022

Accepted: 23 January 2023

First Online: 3 February 2023

Declarations

:

: The authors declare no conflict of interest during the course of this work.

Document is current

Any future updates will be listed below